Related Experiment Video
Updated: May 30, 2026
06:45
Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Current concepts in antifungal pharmacology
1University of Houston College of Pharmacy and The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. rlewis@uh.edu
Mayo Clinic Proceedings
|August 2, 2011
Summary
New antifungal drugs improve invasive mycoses treatment, but limitations in spectrum and drug interactions persist. Strategies like pharmacokinetic-pharmacodynamic optimization enhance antifungal therapy safety and efficacy.
Area of Science:
- Medical Mycology
- Pharmacology
Background:
- Recent advances in antifungal agents (echinocandins, second-generation triazoles) have significantly improved invasive fungal infection management.
- Despite progress, newer antifungals present challenges including limited spectrum, pharmacokinetic variability, drug-drug interactions, and long-term toxicity.
Purpose of the Study:
- To review the pharmacological aspects of systemic antifungal agents.
- To discuss evolving strategies for optimizing antifungal therapy safety and efficacy.
Main Methods:
- Review of current literature on systemic antifungal agents.
- Analysis of pharmacokinetic and pharmacodynamic principles.
- Evaluation of therapeutic drug monitoring and optimization strategies.
Main Results:
- Newer antifungal agents offer improved management but have limitations in activity spectrum and pharmacokinetic profiles.
- Pharmacokinetic-drug interactions and unique toxicities are significant concerns with long-term use.
- Pharmacokinetic-pharmacodynamic optimization and therapeutic drug monitoring show promise for improved outcomes.
Conclusions:
- Optimizing systemic antifungal therapy requires understanding drug pharmacology and employing advanced strategies.
- Pharmacokinetic-pharmacodynamic optimization and therapeutic drug monitoring are crucial for enhancing the safety and efficacy of antifungal treatments.
- Continued research into antifungal agent properties and management strategies is essential for combating invasive mycoses.
More Related Videos
08:54Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
07:19A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:29Overview of Fungi
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...